Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Altria Group Inc (MO) vs Procter & Gamble Co (PG) Price & Performance

Altria Group IncTrade
Procter & Gamble CoTrade

Price performance (Past 24H)

Key statistics

Altria Group Inc vs Procter & Gamble Co — how do they compare? Altria Group Inc trades at $64.87 (market cap $114.13B), while Procter & Gamble Co trades at $145.33 (market cap $340.39B). The key difference: Procter & Gamble Co is far larger — about 3× Altria Group Inc's market cap, and Altria Group Inc pays the higher dividend (6.2%). Which is the better fit depends on your goals.

MOPG
Market Cap
$114.13B$340.39B
Sector
Consumer StaplesConsumer Staples
52-Week High
$74.92$167.18
52-Week Low
$54.72$138.10
Enterprise Value
$136.34B$366.23B
Dividend Yield
6.2%2.97%
Volume
6,423,436

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Altria Group Inc

Altria Group (MO) trades at $68.35, up 0.89% with mixed technical signals showing bearish moving averages but oversold RSI levels. The company maintains strong profitability with 39% net income margin and $6.95B net income for 2025, though revenue declined slightly to $20.14B. Recent earnings show alternating beats and misses, with Q3 2026 results pending. Analyst consensus remains bullish with 61.5% buy ratings and $71.50 price target, while the stock offers a 6.3% dividend yield with 56 consecutive annual increases expected.

MO presents value opportunity with 14.4x P/E ratio and strong cash flow generation, but faces headwinds from cigarette volume declines and regulatory pressures. The smoke-free product transition shows progress but remains early stage. Current price near support at $67 suggests limited downside, while analyst targets indicate 4.6% upside potential. Key risks include litigation exposure and slower-than-expected diversification from traditional tobacco products.

Procter & Gamble Co

Procter & Gamble (PG) trades at $144.84, down 0.64% over 24 hours, with a bearish technical signal from moving averages but neutral oscillators. The company reported strong earnings beats in recent quarters, with Q3 2026 EPS expected at $1.90. Fundamentals show robust profitability, including an 18.44% net income margin and 30.13% ROE, though valuation ratios like P/E of 22.12 and P/S of 4.08 are at premiums. Recent news highlights a WNBA partnership and a rejected mini-tender offer, while cash flow trends indicate stable operations.

PG offers a stable outlook with consistent dividend growth and efficient supply chain improvements, but faces risks from premium valuations and soft demand concerns. Analyst consensus is bullish with a $161.20 price target, though near-term upside may be limited by economic headwinds. Investment appeal lies in its defensive qualities and dividend reliability, balanced against competitive and margin pressures.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Altria Group Inc

Altria comprises Philip Morris USA, U.S. Smokeless Tobacco, John Middleton, Helix Innovations, and Philip Morris Capital, although the company plans to wind down Philip Morris Capital by the end of 2022. It holds a 10% interest in the world's largest brewer, Anheuser-Busch InBev. Through its tobacco subsidiaries, Altria holds the leading position in cigarettes and smokeless tobacco in the United States and the number-two spot in machine-made cigars. The company's Marlboro brand is the leading cigarette brand in the U.S. with a 43% share in 2020. Altria holds strategic investments in JUUL Labs (35% economic interest) and Cronos (42%).

Read more on MO

About Procter & Gamble Co

The Procter & Gamble Company manufactures and markets consumer products in countries throughout the world. The Company provides products in the laundry and cleaning, paper, beauty care, food and beverage, and health care segments. Procter & Gamble products are sold primarily through mass merchandisers, grocery stores, membership club stores, drug stores, and neighborhood stores.

Read more on PG